High levels of retinal docosahexaenoic acid do not protect photoreceptor degeneration in VPP transgenic mice

Molecular Vision

Volumn 16, Issue , 2010, Pages 1669-1679

  Li, Feng ^a,b   Marchette, Lea D ^a,b   Brush, Richard S ^a,b   Elliott, Michael H ^a,b   Davis, Kimberly R ^a,b   Anderson, Ashley G ^a,b   Anderson, Robert E ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAENORHABDITIS ELEGANS PROTEIN; DOCOSAHEXAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; PROTEIN FAT 1; RHODOPSIN; UNCLASSIFIED DRUG;

ALPHA RHYTHM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA RHYTHM; CELL DEATH; CELL LOSS; CONTROLLED STUDY; DISEASE COURSE; ELECTRORETINOGRAM; ELECTRORETINOGRAPHY; FAT INTAKE; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FEMALE; GENOTYPE; LIPID COMPOSITION; MALE; MOUSE; MUTATION; NONHUMAN; PHOTORECEPTOR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINA DEGENERATION; RETINA ROD; TRANSGENIC MOUSE;

ANIMALS; DOCOSAHEXAENOIC ACIDS; ELECTRORETINOGRAPHY; FATTY ACIDS; LIVER; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; PHOTORECEPTOR CELLS, VERTEBRATE; RETINA; RETINAL DEGENERATION; RHODOPSIN;

EID: 77956962034     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Fliesler SJ, Anderson RE. Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res 1983; 22:79-131.
2. Benolken RM, Anderson RE, Wheeler TG. Membrane fatty acids associated with the electrical response in visual excitation. Science 1973; 182:1253-1254.
3. Wheeler TG, Benolken RM, Anderson RE. Visual membrane: specificity of fatty acid precursors for the electrical response to illumination. Science 1975; 188:1312-1314.
4. Neuringer M, Connor WE, Van Patten C, Barstad L. Dietary omega-3 fatty acid deficiency and visual loss in infant rhesus monkeys. J Clin Invest 1984; 73:272-276.
5. Neuringer M, Connor WE, Lin S, Barstad L, Luck S. Biochemical and functional effects of prenatal and postnatal n-3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc Natl Acad Sci USA 1986; 83:4021-4025.
6. Uauy RD, Birch DG, Birch EE, Tyson JE, Hoffman DR. effect of dietary omega-3 fatty acids on retinal function of very-lowweigh neonates. Pediatr Res 1990; 28:485-492.
7. Bush RA, Reme CE. Malnoe. Light damage in the retina: the effect of dietary deprivation of n-3 fatty acids on acute structural alterations. Exp Eye Res 1991; 53:741-752.
8. Birch DG, Birch EE, Hoffman DR, Uauy RD. Retinal development in very-low-birth-weight infants fed diets differing in omega-3 fatty acids. Invest Ophthalmol Vis Sci 1992; 33:2365-2376.
9. Birch EE, Birch DG, Hoffman DR, Uauy R. Dietary essential fatty acid supply and visual acuity development. Invest Ophthalmol Vis Sci 1992; 33:3242-3253.
10. Bourre JM, Francois M, Youyou A, Dumont O, Piciotti M, Pascal G, Durand G. The effects of dietary α-linolenic acid on the composition of nerve membrane, enzymatic activity, amplitude of electro-physiological parameters, resistance to poisons and performance of learning tasks in rats. J Nutr 1989; 119:1880-1892.
11. Converse CA, Hammer HM, Packard CJ, Shepherd J. Plasma lipid abnormalities in retinitis pigmentosa and related condition. Trans Ophthalmol Soc U K 1983; 103:508-512.
12. Converse CA, McLachlan T, Bow AC, Packard CJ, Shepherd J. Lipid metabolism in retinitis pigmentosa. In: Hollyfield JG, Anderson RE, LaVail, MM, editors. Degenerative retinal disorders: clinical and laboratory investigations. Proceedings of the Sendai Symposium on Retinal Degeneration; 1986 Sep 20-24; Sendai, Japan. New York: Alan R Liss; 1987. p. 93-101.
13. Bazan NG, Scott BL, Reddy TS, Pelias MZ. Decreased content of docosahexaenoate and arachidonate in plasma phospholipids in Usher's Syndrome. Biochem Biophys Res Commun 1986; 141:600-604.
14. Anderson RE, Maude MB, Lewis RA, Newsome DA, Fishman GA. Abnormal plasma levels of polyunsaturated fatty acid in autosomal dominant retinitis pigmentosa. Exp Eye Res 1987; 44:155-159.
15. Gong J, Rosner B, Rees DG, Berson EL, Weigel-DiFranco CA, Schaefer EJ. Plasma docosahexaenoic acid levels in various genetic forms of retinitis pigmentosa. Invest Ophthalmol Vis Sci 1992; 33:2596-2602.
16. Hoffman DR, Uauy R, Birch DG. Red blood cell fatty acid levels in patients with autosomal dominant retinitis pigmentosa. Exp Eye Res 1993; 57:359-368.
17. Hoffman DR, Locke KG, Wheaton DH, Fish GE, Spencer R, Birch DG. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa. Am J Ophthalmol 2004; 137:704-718.
18. Hoffman DR, Birch DG. Docosahexaenoic acid in red blood cells of patients with X-linked retinitis pigmentosa. Invest Ophthalmol Vis Sci 1995; 36:1009-1018.
19. Schaefer EJ, Robins SJ, Patton GM, Sandberg MA, Weigel-DiFranco CA, Rosner B, Rees DG, Berson EL. Red blood cell membrane phosphatidylethanolamine fatty acid content in various forms of retinitis pigmentosa. J Lipid Res 1995; 36:1427-1433.
20. Maude MB, Anderson EO, Anderson ER. Polyunsaturated fatty acids are lower in blood lipids of Usher's type I but not Usher's type II. Invest Ophthalmol Vis Sci 1998; 39:2164-2166.
21. Hoffman DR, Birch DG. Omega 3 fatty acid status in patients with retinitis pigmentosa. World Rev Nutr Diet 1998; 83:52-60.
22. Anderson RE, Maude MB, Alvarez RA, Acland GM, Aguirre GD. Plasma lipid abnormalities in the poodle with progressive rod-cone degeneration. Exp Eye Res 1991; 52:349-355.
23. Anderson RE, Maude MB, Nilsson SE, Narfstrom K. Plasma lipid abnormalities in the Abyssinian cat with a hereditary progressive rod-cone degeneration. Exp Eye Res 1991; 53:415-417.
24. Anderson RE, Maude MB, Acland G, Aguirre CD. Plasma lipid changes in PRCD-affected and normal miniature poodles given oral supplements of linseed oil. Indications for the involvement of n-3 fatty acids in inherited retinal degenerations. Exp Eye Res 1994; 58:129-137.
25. Aguirre GD, Acland GM, Maude MB, Anderson RE. Diets enriched in docosahexaenoic acid fail to correct progressive rod-cone degeneration (prcd) phenotype. Invest Ophthalmol Vis Sci 1997; 38:2387-2407.
26. Anderson RE, Maude MB, Narfstrom K, Nilsson SEG. Lipids of plasma, retinal, and retinal pigment epithelium in Swedish Briard dogs with a slowly progressive retinal dystrophy. Exp Eye Res 1997; 64:181-187.
27. Anderson RE, Maude MB, Bok D. Low docosahexaenoic acid levels in rod outer segment membranes of mice with rds/peripherin and P216L peripherin mutations. Invest Ophthalmol Vis Sci 2001; 42:1715-1720.
28. Anderson RE, Sieving PA, Maude MB, Naash MI. Mice with G90D rhodopsin mutations have lower DHA in rod outer segment membranes than control mice. In: Anderson RE, LaVail, MM, Hollyfield JG, editors. New insights into retinal degenerative disease. New York: Kluwer Academic/Plenum Press; 2001. p. 235-245.
29. Anderson RE, Maude MB, McClellan M, Matthes MT, Yasumura D, LaVail MM. Low docosahexaenoic acid levels in rod outer segments of rats with P23H and S334ter rhodopsin mutations. Mol Vis 2002; 8:351-358.
30. Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Moser A, Brockhurst RJ, Hayes KC, Johnson CA, Anderson EJ, Gaudio AR, Willett WC, Schaefer EJ. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Arch Ophthalmol 2004; 122:1306-1314.
31. Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Moser A, Brockhurst RJ, Hayes KC, Johnson CA, Anderson EJ, Gaudio AR, Willett WC, Schaefer EJ. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Arch Ophthalmol 2004; 122:1297-1305.
32. Hoffman DR, Locke KG, Wheaton DH, Fish GE, Spencer R, Birch DG. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa. Am J Ophthalmol 2004; 137:704-718.
33. Martin RE, Ranchon-Cole I, Brush RS, Williamson CR, Hopkins SA, Li F. Anderson RE. P23H and S334ter opsin mutations: Increasing photoreceptor outer segment n-3 fatty acid content does not affect the course of retinal degeneration. Mol Vis 2004; 10:199-207.
34. Li F, Marchette LD, Brush RS, Elliott MH, Le YZ, Henry KA, Anderson AG, Zhao C, Sun X, Zhang K, Anderson RE. DHA does not protect ELOVL4 transgenic mice from retinal degeneration. Mol Vis 2009; 15:1185-1193.
35. Spychalla JP, Kinney AJ, Browse J. Identification of an animal ω-3 fatty acid desaturase by heterologous expression in Arabidopsis. Proc Natl Acad Sci USA 1997; 94:1142-1147.
36. Naash MI, Hollyfield JG, Al-Ubaidi MR, Baehr W. Simulation of human autosomal dominant retinitis pigmentosa in transgenic mice expressing a mutated murine opsin gene. Proc Natl Acad Sci USA 1993; 90:5499-5503.
37. Goto Y, Peachey NS, Ziroli NE, Seiple WH, Cryczan C, Pepperberg DR, Naash MI. Rod phototransduction in transgenic mice expressing a mutant opsin gene. J Opt Soc Am A Opt Image Sci Vis 1996; 13:577-585.
38. Naash MI, Ripps H, Li S, Goto Y, Peachey NS. Polygenic disease and retinitis pigmentosa: albinism exacerbates photoreceptor degeneration induced by the expression of a mutant opsin in transgenic mice. J Neurosci 1996; 16:7853-7858.
39. Wu TH, Ting TD, Okajima TI, Pepperberg DR, Ho YK, Ripps H, Naash MI. Opsin localization and rhodopsin photochemistry in a transgenic mouse model of retinitis pigmentosa. Neuroscience 1998; 87:709-717.
40. Qtaishat NM, Okajima TL, Li S, Naash MI, Pepperberg DR. Retinoid kinetics in eye tissues of VPP transgenic mice and their normal littermates. Invest Ophthalmol Vis Sci 1999; 40:1040-1049.
41. Grimm C, Wenzel A, Stanescu D, Samardzija M, Hotop S, Groszer M, Naash M, Gassmann M, Remé C. Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J Neurosci 2004; 24:5651-5658.
42. Brill E, Malanson KM, Radu RA, Boukharov NV, Wang Z, Chung H, Lloyd MB, Bok D, Travis GH, Obin M, Lem J. A novel form of transducin-dependent retinal degeneration: accelerated retinal degeneration in the absence of rod transducin. Invest Ophthalmol Vis Sci 2007; 48:5445-5453.
43. Dryja TP, McGee TL, Reichel E, Hahn LB, Cowley GS, Yandell DW, Sandberg MA, Berson EL. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature 1990; 343:364-366.
44. Tanito M, Brush RS, Elliott MH, Wicker LD, Henry KR, Anderson RE. High levels of retinal membrane docosahexaenoic acid increase susceptibility to stressinduced degeneration. J Lipid Res 2009; 50:807-819.
45. Kang JX, Wang J, Wu L, Hand ZB. Fat-1 mice convert n-6 to n3 fatty acids. Nature 2004; 427:504.
46. Kang JX. Fat-1 transgenic mice: a new model for omega-3 research. Prostaglandins Leukot Essent Fatty Acids 2007; 77:263-267.
47. Wiegand RD, Koutz CA, Stinson AM, Anderson RE. Conservation of docosahexaenoic acid in rod outer segments of rat retina during n-3 and n-6 fatty acid deficiency. J Neurochem 1991; 57:1690-1699.
48. Niu SL, Mitchell DC, Lim SY, Wen ZM, Kim HY, Salem N Jr, Litman BJ. Reduced G protein-coupled signaling efficiency in retinal rod outer segments in response to n-3 fatty acid deficiency. J Biol Chem 2004; 279:31098-1104.
49. Martin RE, Fliesler SJ, Brush RS, Richards MJ, Hopkins SA, Anderson RE. Lipid differences in rod outer segment membranes of rats with P23H and S334ter opsin mutations. Mol Vis 2005; 11:338-346.
50. Bazan NG. Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease. J Lipid Res 2009; 50:S400-S405.